Title:
The Erythropoietin Promoter Variant rs1617640 Is Not Associated with Severe Retinopathy of Prematurity, Independent of Treatment with Erythropoietin
Author(s):
Dame, Christof; Sciesielski, Lina K.; Rau, Carolin; Badur, Chiara-Aiyleen; Bührer, Christoph
Year of publication:
2018
Available Date:
2022-12-22T07:42:21Z
Abstract:
In this case-control study, the erythropoietin (EPO) promoter variant s1617640, linked to high intravitreal EPO concentrations and increased risk of diabetic retinopathy, was not associated with severe retinopathy of prematurity. This finding was observed both in infants with and without recombinant EPO administration.
Part of Identifier:
e-ISSN (online): 1097-6833
Keywords:
rhEpo treatment
SNP risk allele
retinopathy of prematurity (ROP)
DDC-Classification:
610 Medizin und Gesundheit
Publication Type:
Wissenschaftlicher Artikel
DOI of the Original Publication:
PubMed ID of the Original Publication:
Journaltitle:
The Journal of Pediatrics
Department/institution:
Charité - Universitätsmedizin Berlin
Comments:
Original article first published: 2018-05-03.
